To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome Interventions:   Drug: Rivaroxaban 2.5 Mg Oral Tablet;   Drug: Clopidogrel tablet;   Drug: Aspirin tablet Sponsors:   Sarmad Zahoor;   University of Managemant and Technology, Pakistan;   Mayo Hospital Lahore Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials